The global vascular stents market to grow at a CAGR of 7.38% during the period 2016-2020.
Global Vascular Stents Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The device helps prevent arterial blockages that may occur in people who have undergone angioplasty. It helps maintain the patency of stenotic vessels and avoid re-blockage due to blood accumulation or excessive tissue growth.
A trend which will definitely change the market is the emergence of bio-absorbable stents. Since 1995, the introduction of new products such as bio-absorbable scaffolds, biodegradable polymers, and bifurcation stents is likely to increase the use of vascular stents in interventional cardiology. These stents have the potential to eliminate the complications of durable polymer stents.
This will induce a significant positive shift in the treatment of artery stenosis and encourage affected individuals to undergo vascular stenting. Bio-absorbable stents restore blood flow by opening the clogged blood vessel and provide support until the damaged blood vessel heals. Unlike metallic stents, the body gradually metabolizes the bio-absorbable stent and entirely absorbs them over time. According to the report, a key growth driver is the demand for minimally invasive procedures. Minimally invasive procedures involve smaller incisions. They help prevent excessive blood loss and reduce the duration of recovery and hospital stay. These surgeries also reduce the need for blood transfusions and the risk of infections, cause less pain and scarring, and lead to the better clinical outcome. They help treat individuals who are in critical conditions or ineligible for open surgeries.
These benefits of minimally invasive procedures have led surgeons to implement them for managing different disorders such as an aneurysm, artery stenosis, and plaque in the blood vessel of the heart and other vessel walls of peripheral organs. Physicians are using minimally invasive peripheral vascular stenting to treat chronic limb ischemia.
Further, the report states that one challenge that could restrict market growth is the complications associated with vascular stenting.
To calculate the market size, we consider revenue generated from the sales of:
- Coronary stents: Drug-eluting, bare metal, and bioabsorbable stents - Peripheral vascular stent: Iliac artery, fem-pop artery stents, renal artery, and carotid artery stents
- Abbott Laboratories - Boston Scientific - Cook Medical - Cordis - Medtronic - W.L. Gore & Associates
Other prominent vendors
- AMG International - B. Braun Melsungen - Biosensors International - BIOTRONIK - Fortimedix - Gore Medical - InspireMD - Lepu Medical Technology - MicroPort Scientific - Optimed - Neovasc - Sorin Group - Terumo